US 11311517
Combination of small molecule CD-47 inhibitors with other anti-cancer agents
granted A61KA61K31/4245A61K45/06
Quick answer
US patent 11311517 (Combination of small molecule CD-47 inhibitors with other anti-cancer agents) held by Aurigene Discovery Technologies Limited expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4245, A61K45/06, A61P, A61P35/00